Global Gastrointestinal Stromal Tumor Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Gastrointestinal Stromal Tumor Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Gastrointestinal Stromal Tumor Drug Industry Forecast” looks at past sales and reviews total world Gastrointestinal Stromal Tumor Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Stromal Tumor Drug sales for 2024 through 2030. With Gastrointestinal Stromal Tumor Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Stromal Tumor Drug industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal Stromal Tumor Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal Stromal Tumor Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal Stromal Tumor Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Stromal Tumor Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Stromal Tumor Drug.
United States market for Gastrointestinal Stromal Tumor Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gastrointestinal Stromal Tumor Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gastrointestinal Stromal Tumor Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gastrointestinal Stromal Tumor Drug players cover Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumor Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Gastrointestinal Stromal Tumor Drug market?
What factors are driving Gastrointestinal Stromal Tumor Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gastrointestinal Stromal Tumor Drug market opportunities vary by end market size?
How does Gastrointestinal Stromal Tumor Drug break out by Type, by Application?
The global Gastrointestinal Stromal Tumor Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Gastrointestinal Stromal Tumor Drug Industry Forecast” looks at past sales and reviews total world Gastrointestinal Stromal Tumor Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Stromal Tumor Drug sales for 2024 through 2030. With Gastrointestinal Stromal Tumor Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Stromal Tumor Drug industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal Stromal Tumor Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal Stromal Tumor Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal Stromal Tumor Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Stromal Tumor Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Stromal Tumor Drug.
United States market for Gastrointestinal Stromal Tumor Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gastrointestinal Stromal Tumor Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gastrointestinal Stromal Tumor Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gastrointestinal Stromal Tumor Drug players cover Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumor Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Imatinib
- Sunitinib
- Regorafenib
- Ripretinib
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Bayer Pharmaceuticals
- Glenmark Pharmaceuticals Ltd.
- Sun Pharmaceuticals
- Actavis Generics
- Dr. Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- Apotex Inc.
- Mylan Pharms Inc.
- Bulat Pharmaceutical
- MSN Laboratories
- Vannsh Life Sciences
- Beacon Pharmaceuticals
- Drug International
- Deciphera Pharmaceuticals
- CSPC Pharmaceuticals
- Hansoh Pharmaceuticals
- Kelun Pharmaceuticals
- Zai Lab
- CStone Pharmaceuticals
- China Biopharmaceuticals
What is the 10-year outlook for the global Gastrointestinal Stromal Tumor Drug market?
What factors are driving Gastrointestinal Stromal Tumor Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gastrointestinal Stromal Tumor Drug market opportunities vary by end market size?
How does Gastrointestinal Stromal Tumor Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Gastrointestinal Stromal Tumor Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Gastrointestinal Stromal Tumor Drug by Country/Region, 2019, 2023 & 2030
2.2 Gastrointestinal Stromal Tumor Drug Segment by Type
2.2.1 Imatinib
2.2.2 Sunitinib
2.2.3 Regorafenib
2.2.4 Ripretinib
2.2.5 Others
2.3 Gastrointestinal Stromal Tumor Drug Sales by Type
2.3.1 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Gastrointestinal Stromal Tumor Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Gastrointestinal Stromal Tumor Drug Sale Price by Type (2019-2024)
2.4 Gastrointestinal Stromal Tumor Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Gastrointestinal Stromal Tumor Drug Sales by Application
2.5.1 Global Gastrointestinal Stromal Tumor Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Gastrointestinal Stromal Tumor Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Gastrointestinal Stromal Tumor Drug Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Gastrointestinal Stromal Tumor Drug Breakdown Data by Company
3.1.1 Global Gastrointestinal Stromal Tumor Drug Annual Sales by Company (2019-2024)
3.1.2 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Company (2019-2024)
3.2 Global Gastrointestinal Stromal Tumor Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Company (2019-2024)
3.2.2 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Company (2019-2024)
3.3 Global Gastrointestinal Stromal Tumor Drug Sale Price by Company
3.4 Key Manufacturers Gastrointestinal Stromal Tumor Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastrointestinal Stromal Tumor Drug Product Location Distribution
3.4.2 Players Gastrointestinal Stromal Tumor Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GASTROINTESTINAL STROMAL TUMOR DRUG BY GEOGRAPHIC REGION
4.1 World Historic Gastrointestinal Stromal Tumor Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Gastrointestinal Stromal Tumor Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Gastrointestinal Stromal Tumor Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Gastrointestinal Stromal Tumor Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Gastrointestinal Stromal Tumor Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Gastrointestinal Stromal Tumor Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gastrointestinal Stromal Tumor Drug Sales Growth
4.4 APAC Gastrointestinal Stromal Tumor Drug Sales Growth
4.5 Europe Gastrointestinal Stromal Tumor Drug Sales Growth
4.6 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Growth
5 AMERICAS
5.1 Americas Gastrointestinal Stromal Tumor Drug Sales by Country
5.1.1 Americas Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024)
5.1.2 Americas Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024)
5.2 Americas Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024)
5.3 Americas Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumor Drug Sales by Region
6.1.1 APAC Gastrointestinal Stromal Tumor Drug Sales by Region (2019-2024)
6.1.2 APAC Gastrointestinal Stromal Tumor Drug Revenue by Region (2019-2024)
6.2 APAC Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024)
6.3 APAC Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor Drug by Country
7.1.1 Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024)
7.1.2 Europe Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024)
7.2 Europe Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024)
7.3 Europe Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Stromal Tumor Drug by Country
8.1.1 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024)
8.3 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor Drug
10.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor Drug
10.4 Industry Chain Structure of Gastrointestinal Stromal Tumor Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastrointestinal Stromal Tumor Drug Distributors
11.3 Gastrointestinal Stromal Tumor Drug Customer
12 WORLD FORECAST REVIEW FOR GASTROINTESTINAL STROMAL TUMOR DRUG BY GEOGRAPHIC REGION
12.1 Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Region
12.1.1 Global Gastrointestinal Stromal Tumor Drug Forecast by Region (2025-2030)
12.1.2 Global Gastrointestinal Stromal Tumor Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Gastrointestinal Stromal Tumor Drug Forecast by Type (2025-2030)
12.7 Global Gastrointestinal Stromal Tumor Drug Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.1.3 Novartis Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Bayer Pharmaceuticals
13.2.1 Bayer Pharmaceuticals Company Information
13.2.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Pharmaceuticals Main Business Overview
13.2.5 Bayer Pharmaceuticals Latest Developments
13.3 Glenmark Pharmaceuticals Ltd.
13.3.1 Glenmark Pharmaceuticals Ltd. Company Information
13.3.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Glenmark Pharmaceuticals Ltd. Main Business Overview
13.3.5 Glenmark Pharmaceuticals Ltd. Latest Developments
13.4 Sun Pharmaceuticals
13.4.1 Sun Pharmaceuticals Company Information
13.4.2 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sun Pharmaceuticals Main Business Overview
13.4.5 Sun Pharmaceuticals Latest Developments
13.5 Actavis Generics
13.5.1 Actavis Generics Company Information
13.5.2 Actavis Generics Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Actavis Generics Main Business Overview
13.5.5 Actavis Generics Latest Developments
13.6 Dr. Reddy's Laboratories
13.6.1 Dr. Reddy's Laboratories Company Information
13.6.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Dr. Reddy's Laboratories Main Business Overview
13.6.5 Dr. Reddy's Laboratories Latest Developments
13.7 Teva Pharmaceutical Industries Ltd.
13.7.1 Teva Pharmaceutical Industries Ltd. Company Information
13.7.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.8 Apotex Inc.
13.8.1 Apotex Inc. Company Information
13.8.2 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Apotex Inc. Main Business Overview
13.8.5 Apotex Inc. Latest Developments
13.9 Mylan Pharms Inc.
13.9.1 Mylan Pharms Inc. Company Information
13.9.2 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Mylan Pharms Inc. Main Business Overview
13.9.5 Mylan Pharms Inc. Latest Developments
13.10 Bulat Pharmaceutical
13.10.1 Bulat Pharmaceutical Company Information
13.10.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Bulat Pharmaceutical Main Business Overview
13.10.5 Bulat Pharmaceutical Latest Developments
13.11 MSN Laboratories
13.11.1 MSN Laboratories Company Information
13.11.2 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 MSN Laboratories Main Business Overview
13.11.5 MSN Laboratories Latest Developments
13.12 Vannsh Life Sciences
13.12.1 Vannsh Life Sciences Company Information
13.12.2 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Vannsh Life Sciences Main Business Overview
13.12.5 Vannsh Life Sciences Latest Developments
13.13 Beacon Pharmaceuticals
13.13.1 Beacon Pharmaceuticals Company Information
13.13.2 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Beacon Pharmaceuticals Main Business Overview
13.13.5 Beacon Pharmaceuticals Latest Developments
13.14 Drug International
13.14.1 Drug International Company Information
13.14.2 Drug International Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.14.3 Drug International Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Drug International Main Business Overview
13.14.5 Drug International Latest Developments
13.15 Deciphera Pharmaceuticals
13.15.1 Deciphera Pharmaceuticals Company Information
13.15.2 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Deciphera Pharmaceuticals Main Business Overview
13.15.5 Deciphera Pharmaceuticals Latest Developments
13.16 CSPC Pharmaceuticals
13.16.1 CSPC Pharmaceuticals Company Information
13.16.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 CSPC Pharmaceuticals Main Business Overview
13.16.5 CSPC Pharmaceuticals Latest Developments
13.17 Hansoh Pharmaceuticals
13.17.1 Hansoh Pharmaceuticals Company Information
13.17.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Hansoh Pharmaceuticals Main Business Overview
13.17.5 Hansoh Pharmaceuticals Latest Developments
13.18 Kelun Pharmaceuticals
13.18.1 Kelun Pharmaceuticals Company Information
13.18.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Kelun Pharmaceuticals Main Business Overview
13.18.5 Kelun Pharmaceuticals Latest Developments
13.19 Zai Lab
13.19.1 Zai Lab Company Information
13.19.2 Zai Lab Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Zai Lab Main Business Overview
13.19.5 Zai Lab Latest Developments
13.20 CStone Pharmaceuticals
13.20.1 CStone Pharmaceuticals Company Information
13.20.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 CStone Pharmaceuticals Main Business Overview
13.20.5 CStone Pharmaceuticals Latest Developments
13.21 China Biopharmaceuticals
13.21.1 China Biopharmaceuticals Company Information
13.21.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 China Biopharmaceuticals Main Business Overview
13.21.5 China Biopharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
br>
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Gastrointestinal Stromal Tumor Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Gastrointestinal Stromal Tumor Drug by Country/Region, 2019, 2023 & 2030
2.2 Gastrointestinal Stromal Tumor Drug Segment by Type
2.2.1 Imatinib
2.2.2 Sunitinib
2.2.3 Regorafenib
2.2.4 Ripretinib
2.2.5 Others
2.3 Gastrointestinal Stromal Tumor Drug Sales by Type
2.3.1 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Gastrointestinal Stromal Tumor Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Gastrointestinal Stromal Tumor Drug Sale Price by Type (2019-2024)
2.4 Gastrointestinal Stromal Tumor Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Gastrointestinal Stromal Tumor Drug Sales by Application
2.5.1 Global Gastrointestinal Stromal Tumor Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Gastrointestinal Stromal Tumor Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Gastrointestinal Stromal Tumor Drug Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Gastrointestinal Stromal Tumor Drug Breakdown Data by Company
3.1.1 Global Gastrointestinal Stromal Tumor Drug Annual Sales by Company (2019-2024)
3.1.2 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Company (2019-2024)
3.2 Global Gastrointestinal Stromal Tumor Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Company (2019-2024)
3.2.2 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Company (2019-2024)
3.3 Global Gastrointestinal Stromal Tumor Drug Sale Price by Company
3.4 Key Manufacturers Gastrointestinal Stromal Tumor Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastrointestinal Stromal Tumor Drug Product Location Distribution
3.4.2 Players Gastrointestinal Stromal Tumor Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GASTROINTESTINAL STROMAL TUMOR DRUG BY GEOGRAPHIC REGION
4.1 World Historic Gastrointestinal Stromal Tumor Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Gastrointestinal Stromal Tumor Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Gastrointestinal Stromal Tumor Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Gastrointestinal Stromal Tumor Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Gastrointestinal Stromal Tumor Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Gastrointestinal Stromal Tumor Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gastrointestinal Stromal Tumor Drug Sales Growth
4.4 APAC Gastrointestinal Stromal Tumor Drug Sales Growth
4.5 Europe Gastrointestinal Stromal Tumor Drug Sales Growth
4.6 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Growth
5 AMERICAS
5.1 Americas Gastrointestinal Stromal Tumor Drug Sales by Country
5.1.1 Americas Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024)
5.1.2 Americas Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024)
5.2 Americas Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024)
5.3 Americas Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumor Drug Sales by Region
6.1.1 APAC Gastrointestinal Stromal Tumor Drug Sales by Region (2019-2024)
6.1.2 APAC Gastrointestinal Stromal Tumor Drug Revenue by Region (2019-2024)
6.2 APAC Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024)
6.3 APAC Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor Drug by Country
7.1.1 Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024)
7.1.2 Europe Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024)
7.2 Europe Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024)
7.3 Europe Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Stromal Tumor Drug by Country
8.1.1 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024)
8.3 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor Drug
10.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor Drug
10.4 Industry Chain Structure of Gastrointestinal Stromal Tumor Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastrointestinal Stromal Tumor Drug Distributors
11.3 Gastrointestinal Stromal Tumor Drug Customer
12 WORLD FORECAST REVIEW FOR GASTROINTESTINAL STROMAL TUMOR DRUG BY GEOGRAPHIC REGION
12.1 Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Region
12.1.1 Global Gastrointestinal Stromal Tumor Drug Forecast by Region (2025-2030)
12.1.2 Global Gastrointestinal Stromal Tumor Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Gastrointestinal Stromal Tumor Drug Forecast by Type (2025-2030)
12.7 Global Gastrointestinal Stromal Tumor Drug Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.1.3 Novartis Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Bayer Pharmaceuticals
13.2.1 Bayer Pharmaceuticals Company Information
13.2.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Pharmaceuticals Main Business Overview
13.2.5 Bayer Pharmaceuticals Latest Developments
13.3 Glenmark Pharmaceuticals Ltd.
13.3.1 Glenmark Pharmaceuticals Ltd. Company Information
13.3.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Glenmark Pharmaceuticals Ltd. Main Business Overview
13.3.5 Glenmark Pharmaceuticals Ltd. Latest Developments
13.4 Sun Pharmaceuticals
13.4.1 Sun Pharmaceuticals Company Information
13.4.2 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sun Pharmaceuticals Main Business Overview
13.4.5 Sun Pharmaceuticals Latest Developments
13.5 Actavis Generics
13.5.1 Actavis Generics Company Information
13.5.2 Actavis Generics Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Actavis Generics Main Business Overview
13.5.5 Actavis Generics Latest Developments
13.6 Dr. Reddy's Laboratories
13.6.1 Dr. Reddy's Laboratories Company Information
13.6.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Dr. Reddy's Laboratories Main Business Overview
13.6.5 Dr. Reddy's Laboratories Latest Developments
13.7 Teva Pharmaceutical Industries Ltd.
13.7.1 Teva Pharmaceutical Industries Ltd. Company Information
13.7.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.8 Apotex Inc.
13.8.1 Apotex Inc. Company Information
13.8.2 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Apotex Inc. Main Business Overview
13.8.5 Apotex Inc. Latest Developments
13.9 Mylan Pharms Inc.
13.9.1 Mylan Pharms Inc. Company Information
13.9.2 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Mylan Pharms Inc. Main Business Overview
13.9.5 Mylan Pharms Inc. Latest Developments
13.10 Bulat Pharmaceutical
13.10.1 Bulat Pharmaceutical Company Information
13.10.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Bulat Pharmaceutical Main Business Overview
13.10.5 Bulat Pharmaceutical Latest Developments
13.11 MSN Laboratories
13.11.1 MSN Laboratories Company Information
13.11.2 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 MSN Laboratories Main Business Overview
13.11.5 MSN Laboratories Latest Developments
13.12 Vannsh Life Sciences
13.12.1 Vannsh Life Sciences Company Information
13.12.2 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Vannsh Life Sciences Main Business Overview
13.12.5 Vannsh Life Sciences Latest Developments
13.13 Beacon Pharmaceuticals
13.13.1 Beacon Pharmaceuticals Company Information
13.13.2 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Beacon Pharmaceuticals Main Business Overview
13.13.5 Beacon Pharmaceuticals Latest Developments
13.14 Drug International
13.14.1 Drug International Company Information
13.14.2 Drug International Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.14.3 Drug International Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Drug International Main Business Overview
13.14.5 Drug International Latest Developments
13.15 Deciphera Pharmaceuticals
13.15.1 Deciphera Pharmaceuticals Company Information
13.15.2 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Deciphera Pharmaceuticals Main Business Overview
13.15.5 Deciphera Pharmaceuticals Latest Developments
13.16 CSPC Pharmaceuticals
13.16.1 CSPC Pharmaceuticals Company Information
13.16.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 CSPC Pharmaceuticals Main Business Overview
13.16.5 CSPC Pharmaceuticals Latest Developments
13.17 Hansoh Pharmaceuticals
13.17.1 Hansoh Pharmaceuticals Company Information
13.17.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Hansoh Pharmaceuticals Main Business Overview
13.17.5 Hansoh Pharmaceuticals Latest Developments
13.18 Kelun Pharmaceuticals
13.18.1 Kelun Pharmaceuticals Company Information
13.18.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Kelun Pharmaceuticals Main Business Overview
13.18.5 Kelun Pharmaceuticals Latest Developments
13.19 Zai Lab
13.19.1 Zai Lab Company Information
13.19.2 Zai Lab Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Zai Lab Main Business Overview
13.19.5 Zai Lab Latest Developments
13.20 CStone Pharmaceuticals
13.20.1 CStone Pharmaceuticals Company Information
13.20.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 CStone Pharmaceuticals Main Business Overview
13.20.5 CStone Pharmaceuticals Latest Developments
13.21 China Biopharmaceuticals
13.21.1 China Biopharmaceuticals Company Information
13.21.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
13.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 China Biopharmaceuticals Main Business Overview
13.21.5 China Biopharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
br>
LIST OF TABLES
Table 1. Gastrointestinal Stromal Tumor Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Gastrointestinal Stromal Tumor Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Imatinib
Table 4. Major Players of Sunitinib
Table 5. Major Players of Regorafenib
Table 6. Major Players of Ripretinib
Table 7. Major Players of Others
Table 8. Global Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Table 10. Global Gastrointestinal Stromal Tumor Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Gastrointestinal Stromal Tumor Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Gastrointestinal Stromal Tumor Drug Sale by Application (2019-2024) & (K Units)
Table 14. Global Gastrointestinal Stromal Tumor Drug Sale Market Share by Application (2019-2024)
Table 15. Global Gastrointestinal Stromal Tumor Drug Revenue by Application (2019-2024) & ($ million)
Table 16. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application (2019-2024)
Table 17. Global Gastrointestinal Stromal Tumor Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Gastrointestinal Stromal Tumor Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Company (2019-2024)
Table 20. Global Gastrointestinal Stromal Tumor Drug Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Gastrointestinal Stromal Tumor Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Gastrointestinal Stromal Tumor Drug Producing Area Distribution and Sales Area
Table 24. Players Gastrointestinal Stromal Tumor Drug Products Offered
Table 25. Gastrointestinal Stromal Tumor Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Gastrointestinal Stromal Tumor Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Gastrointestinal Stromal Tumor Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Gastrointestinal Stromal Tumor Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Gastrointestinal Stromal Tumor Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Gastrointestinal Stromal Tumor Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 40. Americas Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024) & (K Units)
Table 41. APAC Gastrointestinal Stromal Tumor Drug Sales by Region (2019-2024) & (K Units)
Table 42. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Gastrointestinal Stromal Tumor Drug Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 45. APAC Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024) & (K Units)
Table 46. Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024) & (K Units)
Table 47. Europe Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 49. Europe Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Gastrointestinal Stromal Tumor Drug Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 53. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumor Drug
Table 55. Key Market Challenges & Risks of Gastrointestinal Stromal Tumor Drug
Table 56. Key Industry Trends of Gastrointestinal Stromal Tumor Drug
Table 57. Gastrointestinal Stromal Tumor Drug Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Gastrointestinal Stromal Tumor Drug Distributors List
Table 60. Gastrointestinal Stromal Tumor Drug Customer List
Table 61. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Global Gastrointestinal Stromal Tumor Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 64. Americas Gastrointestinal Stromal Tumor Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Gastrointestinal Stromal Tumor Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 66. APAC Gastrointestinal Stromal Tumor Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Europe Gastrointestinal Stromal Tumor Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Gastrointestinal Stromal Tumor Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 72. Global Gastrointestinal Stromal Tumor Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 74. Global Gastrointestinal Stromal Tumor Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. Novartis Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Novartis Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 77. Novartis Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Main Business
Table 79. Novartis Latest Developments
Table 80. Bayer Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 82. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Pharmaceuticals Main Business
Table 84. Bayer Pharmaceuticals Latest Developments
Table 85. Glenmark Pharmaceuticals Ltd. Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 87. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Glenmark Pharmaceuticals Ltd. Main Business
Table 89. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 90. Sun Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 92. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sun Pharmaceuticals Main Business
Table 94. Sun Pharmaceuticals Latest Developments
Table 95. Actavis Generics Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Actavis Generics Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 97. Actavis Generics Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Actavis Generics Main Business
Table 99. Actavis Generics Latest Developments
Table 100. Dr. Reddy's Laboratories Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 102. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Dr. Reddy's Laboratories Main Business
Table 104. Dr. Reddy's Laboratories Latest Developments
Table 105. Teva Pharmaceutical Industries Ltd. Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 107. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Teva Pharmaceutical Industries Ltd. Main Business
Table 109. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 110. Apotex Inc. Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 112. Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Apotex Inc. Main Business
Table 114. Apotex Inc. Latest Developments
Table 115. Mylan Pharms Inc. Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 117. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Mylan Pharms Inc. Main Business
Table 119. Mylan Pharms Inc. Latest Developments
Table 120. Bulat Pharmaceutical Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 122. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Bulat Pharmaceutical Main Business
Table 124. Bulat Pharmaceutical Latest Developments
Table 125. MSN Laboratories Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 127. MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. MSN Laboratories Main Business
Table 129. MSN Laboratories Latest Developments
Table 130. Vannsh Life Sciences Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 132. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Vannsh Life Sciences Main Business
Table 134. Vannsh Life Sciences Latest Developments
Table 135. Beacon Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 137. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Beacon Pharmaceuticals Main Business
Table 139. Beacon Pharmaceuticals Latest Developments
Table 140. Drug International Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. Drug International Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 142. Drug International Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Drug International Main Business
Table 144. Drug International Latest Developments
Table 145. Deciphera Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 147. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Deciphera Pharmaceuticals Main Business
Table 149. Deciphera Pharmaceuticals Latest Developments
Table 150. CSPC Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 151. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 152. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. CSPC Pharmaceuticals Main Business
Table 154. CSPC Pharmaceuticals Latest Developments
Table 155. Hansoh Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 156. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 157. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Hansoh Pharmaceuticals Main Business
Table 159. Hansoh Pharmaceuticals Latest Developments
Table 160. Kelun Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 161. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 162. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Kelun Pharmaceuticals Main Business
Table 164. Kelun Pharmaceuticals Latest Developments
Table 165. Zai Lab Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 166. Zai Lab Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 167. Zai Lab Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Zai Lab Main Business
Table 169. Zai Lab Latest Developments
Table 170. CStone Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 171. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 172. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. CStone Pharmaceuticals Main Business
Table 174. CStone Pharmaceuticals Latest Developments
Table 175. China Biopharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 176. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 177. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. China Biopharmaceuticals Main Business
Table 179. China Biopharmaceuticals Latest Developments
br>
Table 1. Gastrointestinal Stromal Tumor Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Gastrointestinal Stromal Tumor Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Imatinib
Table 4. Major Players of Sunitinib
Table 5. Major Players of Regorafenib
Table 6. Major Players of Ripretinib
Table 7. Major Players of Others
Table 8. Global Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Table 10. Global Gastrointestinal Stromal Tumor Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Gastrointestinal Stromal Tumor Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Gastrointestinal Stromal Tumor Drug Sale by Application (2019-2024) & (K Units)
Table 14. Global Gastrointestinal Stromal Tumor Drug Sale Market Share by Application (2019-2024)
Table 15. Global Gastrointestinal Stromal Tumor Drug Revenue by Application (2019-2024) & ($ million)
Table 16. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application (2019-2024)
Table 17. Global Gastrointestinal Stromal Tumor Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Gastrointestinal Stromal Tumor Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Company (2019-2024)
Table 20. Global Gastrointestinal Stromal Tumor Drug Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Gastrointestinal Stromal Tumor Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Gastrointestinal Stromal Tumor Drug Producing Area Distribution and Sales Area
Table 24. Players Gastrointestinal Stromal Tumor Drug Products Offered
Table 25. Gastrointestinal Stromal Tumor Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Gastrointestinal Stromal Tumor Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Gastrointestinal Stromal Tumor Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Gastrointestinal Stromal Tumor Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Gastrointestinal Stromal Tumor Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Gastrointestinal Stromal Tumor Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 40. Americas Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024) & (K Units)
Table 41. APAC Gastrointestinal Stromal Tumor Drug Sales by Region (2019-2024) & (K Units)
Table 42. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Gastrointestinal Stromal Tumor Drug Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 45. APAC Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024) & (K Units)
Table 46. Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024) & (K Units)
Table 47. Europe Gastrointestinal Stromal Tumor Drug Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 49. Europe Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Gastrointestinal Stromal Tumor Drug Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2024) & (K Units)
Table 53. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumor Drug
Table 55. Key Market Challenges & Risks of Gastrointestinal Stromal Tumor Drug
Table 56. Key Industry Trends of Gastrointestinal Stromal Tumor Drug
Table 57. Gastrointestinal Stromal Tumor Drug Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Gastrointestinal Stromal Tumor Drug Distributors List
Table 60. Gastrointestinal Stromal Tumor Drug Customer List
Table 61. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Global Gastrointestinal Stromal Tumor Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 64. Americas Gastrointestinal Stromal Tumor Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Gastrointestinal Stromal Tumor Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 66. APAC Gastrointestinal Stromal Tumor Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Europe Gastrointestinal Stromal Tumor Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Gastrointestinal Stromal Tumor Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 72. Global Gastrointestinal Stromal Tumor Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 74. Global Gastrointestinal Stromal Tumor Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. Novartis Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Novartis Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 77. Novartis Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Main Business
Table 79. Novartis Latest Developments
Table 80. Bayer Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 82. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Pharmaceuticals Main Business
Table 84. Bayer Pharmaceuticals Latest Developments
Table 85. Glenmark Pharmaceuticals Ltd. Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 87. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Glenmark Pharmaceuticals Ltd. Main Business
Table 89. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 90. Sun Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 92. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sun Pharmaceuticals Main Business
Table 94. Sun Pharmaceuticals Latest Developments
Table 95. Actavis Generics Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Actavis Generics Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 97. Actavis Generics Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Actavis Generics Main Business
Table 99. Actavis Generics Latest Developments
Table 100. Dr. Reddy's Laboratories Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 102. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Dr. Reddy's Laboratories Main Business
Table 104. Dr. Reddy's Laboratories Latest Developments
Table 105. Teva Pharmaceutical Industries Ltd. Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 107. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Teva Pharmaceutical Industries Ltd. Main Business
Table 109. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 110. Apotex Inc. Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 112. Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Apotex Inc. Main Business
Table 114. Apotex Inc. Latest Developments
Table 115. Mylan Pharms Inc. Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 117. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Mylan Pharms Inc. Main Business
Table 119. Mylan Pharms Inc. Latest Developments
Table 120. Bulat Pharmaceutical Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 122. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Bulat Pharmaceutical Main Business
Table 124. Bulat Pharmaceutical Latest Developments
Table 125. MSN Laboratories Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 127. MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. MSN Laboratories Main Business
Table 129. MSN Laboratories Latest Developments
Table 130. Vannsh Life Sciences Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 132. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Vannsh Life Sciences Main Business
Table 134. Vannsh Life Sciences Latest Developments
Table 135. Beacon Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 137. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Beacon Pharmaceuticals Main Business
Table 139. Beacon Pharmaceuticals Latest Developments
Table 140. Drug International Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. Drug International Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 142. Drug International Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Drug International Main Business
Table 144. Drug International Latest Developments
Table 145. Deciphera Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 147. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Deciphera Pharmaceuticals Main Business
Table 149. Deciphera Pharmaceuticals Latest Developments
Table 150. CSPC Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 151. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 152. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. CSPC Pharmaceuticals Main Business
Table 154. CSPC Pharmaceuticals Latest Developments
Table 155. Hansoh Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 156. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 157. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Hansoh Pharmaceuticals Main Business
Table 159. Hansoh Pharmaceuticals Latest Developments
Table 160. Kelun Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 161. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 162. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Kelun Pharmaceuticals Main Business
Table 164. Kelun Pharmaceuticals Latest Developments
Table 165. Zai Lab Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 166. Zai Lab Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 167. Zai Lab Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Zai Lab Main Business
Table 169. Zai Lab Latest Developments
Table 170. CStone Pharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 171. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 172. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. CStone Pharmaceuticals Main Business
Table 174. CStone Pharmaceuticals Latest Developments
Table 175. China Biopharmaceuticals Basic Information, Gastrointestinal Stromal Tumor Drug Manufacturing Base, Sales Area and Its Competitors
Table 176. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolios and Specifications
Table 177. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. China Biopharmaceuticals Main Business
Table 179. China Biopharmaceuticals Latest Developments
br>
LIST OF FIGURES
Figure 1. Picture of Gastrointestinal Stromal Tumor Drug
Figure 2. Gastrointestinal Stromal Tumor Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Gastrointestinal Stromal Tumor Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Gastrointestinal Stromal Tumor Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Gastrointestinal Stromal Tumor Drug Sales Market Share by Country/Region (2023)
Figure 10. Gastrointestinal Stromal Tumor Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Imatinib
Figure 12. Product Picture of Sunitinib
Figure 13. Product Picture of Regorafenib
Figure 14. Product Picture of Ripretinib
Figure 15. Product Picture of Others
Figure 16. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type in 2023
Figure 17. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type (2019-2024)
Figure 18. Gastrointestinal Stromal Tumor Drug Consumed in Hospital
Figure 19. Global Gastrointestinal Stromal Tumor Drug Market: Hospital (2019-2024) & (K Units)
Figure 20. Gastrointestinal Stromal Tumor Drug Consumed in Clinic
Figure 21. Global Gastrointestinal Stromal Tumor Drug Market: Clinic (2019-2024) & (K Units)
Figure 22. Gastrointestinal Stromal Tumor Drug Consumed in Others
Figure 23. Global Gastrointestinal Stromal Tumor Drug Market: Others (2019-2024) & (K Units)
Figure 24. Global Gastrointestinal Stromal Tumor Drug Sale Market Share by Application (2023)
Figure 25. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application in 2023
Figure 26. Gastrointestinal Stromal Tumor Drug Sales by Company in 2023 (K Units)
Figure 27. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Company in 2023
Figure 28. Gastrointestinal Stromal Tumor Drug Revenue by Company in 2023 ($ millions)
Figure 29. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Company in 2023
Figure 30. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Gastrointestinal Stromal Tumor Drug Sales 2019-2024 (K Units)
Figure 33. Americas Gastrointestinal Stromal Tumor Drug Revenue 2019-2024 ($ millions)
Figure 34. APAC Gastrointestinal Stromal Tumor Drug Sales 2019-2024 (K Units)
Figure 35. APAC Gastrointestinal Stromal Tumor Drug Revenue 2019-2024 ($ millions)
Figure 36. Europe Gastrointestinal Stromal Tumor Drug Sales 2019-2024 (K Units)
Figure 37. Europe Gastrointestinal Stromal Tumor Drug Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Gastrointestinal Stromal Tumor Drug Revenue 2019-2024 ($ millions)
Figure 40. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2023
Figure 41. Americas Gastrointestinal Stromal Tumor Drug Revenue Market Share by Country (2019-2024)
Figure 42. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Figure 43. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2019-2024)
Figure 44. United States Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share by Region in 2023
Figure 49. APAC Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2019-2024)
Figure 50. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Figure 51. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2019-2024)
Figure 52. China Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 56. India Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2023
Figure 60. Europe Gastrointestinal Stromal Tumor Drug Revenue Market Share by Country (2019-2024)
Figure 61. Europe Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Figure 62. Europe Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2019-2024)
Figure 63. Germany Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 64. France Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2019-2024)
Figure 71. Egypt Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor Drug in 2023
Figure 77. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor Drug
Figure 78. Industry Chain Structure of Gastrointestinal Stromal Tumor Drug
Figure 79. Channels of Distribution
Figure 80. Global Gastrointestinal Stromal Tumor Drug Sales Market Forecast by Region (2025-2030)
Figure 81. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Gastrointestinal Stromal Tumor Drug Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Gastrointestinal Stromal Tumor Drug Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Gastrointestinal Stromal Tumor Drug
Figure 2. Gastrointestinal Stromal Tumor Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Gastrointestinal Stromal Tumor Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Gastrointestinal Stromal Tumor Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Gastrointestinal Stromal Tumor Drug Sales Market Share by Country/Region (2023)
Figure 10. Gastrointestinal Stromal Tumor Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Imatinib
Figure 12. Product Picture of Sunitinib
Figure 13. Product Picture of Regorafenib
Figure 14. Product Picture of Ripretinib
Figure 15. Product Picture of Others
Figure 16. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type in 2023
Figure 17. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type (2019-2024)
Figure 18. Gastrointestinal Stromal Tumor Drug Consumed in Hospital
Figure 19. Global Gastrointestinal Stromal Tumor Drug Market: Hospital (2019-2024) & (K Units)
Figure 20. Gastrointestinal Stromal Tumor Drug Consumed in Clinic
Figure 21. Global Gastrointestinal Stromal Tumor Drug Market: Clinic (2019-2024) & (K Units)
Figure 22. Gastrointestinal Stromal Tumor Drug Consumed in Others
Figure 23. Global Gastrointestinal Stromal Tumor Drug Market: Others (2019-2024) & (K Units)
Figure 24. Global Gastrointestinal Stromal Tumor Drug Sale Market Share by Application (2023)
Figure 25. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application in 2023
Figure 26. Gastrointestinal Stromal Tumor Drug Sales by Company in 2023 (K Units)
Figure 27. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Company in 2023
Figure 28. Gastrointestinal Stromal Tumor Drug Revenue by Company in 2023 ($ millions)
Figure 29. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Company in 2023
Figure 30. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Gastrointestinal Stromal Tumor Drug Sales 2019-2024 (K Units)
Figure 33. Americas Gastrointestinal Stromal Tumor Drug Revenue 2019-2024 ($ millions)
Figure 34. APAC Gastrointestinal Stromal Tumor Drug Sales 2019-2024 (K Units)
Figure 35. APAC Gastrointestinal Stromal Tumor Drug Revenue 2019-2024 ($ millions)
Figure 36. Europe Gastrointestinal Stromal Tumor Drug Sales 2019-2024 (K Units)
Figure 37. Europe Gastrointestinal Stromal Tumor Drug Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Gastrointestinal Stromal Tumor Drug Revenue 2019-2024 ($ millions)
Figure 40. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2023
Figure 41. Americas Gastrointestinal Stromal Tumor Drug Revenue Market Share by Country (2019-2024)
Figure 42. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Figure 43. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2019-2024)
Figure 44. United States Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share by Region in 2023
Figure 49. APAC Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2019-2024)
Figure 50. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Figure 51. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2019-2024)
Figure 52. China Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 56. India Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2023
Figure 60. Europe Gastrointestinal Stromal Tumor Drug Revenue Market Share by Country (2019-2024)
Figure 61. Europe Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Figure 62. Europe Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2019-2024)
Figure 63. Germany Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 64. France Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2019-2024)
Figure 71. Egypt Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Gastrointestinal Stromal Tumor Drug Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor Drug in 2023
Figure 77. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor Drug
Figure 78. Industry Chain Structure of Gastrointestinal Stromal Tumor Drug
Figure 79. Channels of Distribution
Figure 80. Global Gastrointestinal Stromal Tumor Drug Sales Market Forecast by Region (2025-2030)
Figure 81. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Gastrointestinal Stromal Tumor Drug Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Gastrointestinal Stromal Tumor Drug Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share Forecast by Application (2025-2030)
